✦ LIBER ✦

P.3.062 Switch from atypical APs to long-acting risperidone: patient perspective

Book ID: 118591980
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 117 KB
Volume: 15
Category: Article
ISSN: 0924-977X
DOI: 10.1016/s0924-977x(05)80998-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.3.046 Change in prepulse inhibition af

P.3.046 Change in prepulse inhibition after switching schizophrenic patients from zuclopenthixol to long-acting injectable risperidone

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 115 KB

Effects of switching to long-acting inje

Effects of switching to long-acting injectable risperidone from oral atypical antipsychotics on cognitive function in patients with schizophrenia

✍ Sung-Wan Kim; Il-Seon Shin; Jae-Min Kim; Seung-Hyun Lee; Yo-Han Lee; Su-Jin Yang 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 2 views

## Abstract ## Objective To investigate changes in cognitive function and clinical features following a switch from oral atypical antipsychotics (AAPs) to long‐acting injectable risperidone (LAIR) in patients with schizophrenia. ## Methods Thirty‐six patients with schizophrenia treated with oral

P.3.a.008 Efficacy and safety of long-ac

P.3.a.008 Efficacy and safety of long-acting risperidone injection after switching from antipsychotics in Chinese patients

✍ H.F. Li; N.F. Gu; M. Zhou; F.J. Jia; Z.H. Zhao; J.X. Fan; G. Wang; X.L. Sun; M. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 67 KB

P.3.011 Patients treated with different

P.3.011 Patients treated with different conventional depot medications improve similarly after switch to risperidone long-acting injectable

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 226 KB

P.3.c.009 Effects of switching to risper

P.3.c.009 Effects of switching to risperidone long-acting injection on cognitive function in schizophrenia

✍ H. Suzuki; Y. Inoue; M. Otomo; Y. Kawaguchi; K. Gen 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Switching stable patients with schizophr

Switching stable patients with schizophrenia from depot and oral antipsychotics to long-acting injectable risperidone: reasons for switching and safety

✍ Chris Hawley; Martin Turner; Muhammud A Latif; Vivienne Curtis; Packeruther T Sa 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 171 KB 👁 2 views

## Abstract ## Objective An international, non‐randomised study evaluated efficacy and safety of risperidone long‐acting injectable (RLAI) compared to previous treatment. To investigate generisability of the European data set to the UK subset safety and switching data are reported here. ## Method